Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects

Therapeutic Drug Monitoring

Volumn 20, Issue 4, 1998, Pages 371-375

  Xiao Dong, S ^a   Zhi Ping, Z ^a   Zhong Xiao, W ^a   Chong Shu, C ^a   Bartoli, A ^c   Gatti, G ^c   D'Urso, S ^c   Perucca, Emilio ^b  

^a Great Wall Hospital   (China)

^b UNIVERSITY OF PAVIA   (Italy)

^c NONE

Author keywords

Cigarette smoking; Cytochrome CYP1A2; Enzyme induction; Ethnopharmacology; Paracetamol; Phenacetin

Indexed keywords

CYTOCHROME; PARACETAMOL; PHENACETIN;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG DISPOSITION; ENZYME ACTIVITY; ENZYME INDUCTION; ETHNOPHARMACOLOGY; FEMALE; HUMAN; MALE; PASSIVE SMOKING; PRIORITY JOURNAL;

ADULT; AGED; ANIMALS; CHINA; CYTOCHROME P-450 CYP1A2; FEMALE; HUMANS; MALE; MIDDLE AGED; PHENACETIN; SMOKING; TOBACCO SMOKE POLLUTION;

EID: 0345403565     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199808000-00002     Document Type: Article

References (23)

1. Ioannides C, Parke DV. The cytochrome P450 1 gene family of microsomal haemoproteins and their role in the metabolic activation of chemicals. Drug Metab Rev 1990;22:1-85.
2. Parkinson A, Hurwitz A. Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects. Gastroenterology 1991;100:1157-62.
3. Boobis AR, Lynch AM, Murray S, et al. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res 1994;54:89-94.
4. Ha HR, Chen J, Freiburghaus AU, Follath F. Metabolism of theophylline by cDNA-expressed human cytochromes P-450. Br J Clin Pharmacol 1995;39:321-6.
5. Brockmoller J, Roots I. Assessment of liver metabolic function: clinical implications. Clin Pharmacokinet 1994;27:216-8.
6. Bertilsson L, Carrillo JA, Dahl M-L, et al. CLozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Br J Clin Pharmacol 1994;38:471-3.
7. Lemoine A, Gautier JC, Azoulay D, et al. The major pathway of imipramine metabolism is catalized by cytochromes P4501A2 and P4503A4 in human liver. Mol Pharmacol 1993;43:827-32.
8. Kerr BM, Boulding-Brown SY, Lee CA. Cytochrome P450 metabolism of ondansetron by CYP1A2, CYP1A1, and CYP2D6. Paper presented at: Proceedings of the Fifth North American ISSX Meeting; 1993; Tucson, AZ.
9. Yoshimoto K, Echizen H, Chiba K, Tani M, Ishizaki T. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers: N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol 1995;39:421-32.
10. Miller LG. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics. Clin Pharmacokinet 1989;17:90-108.
11. Pantuck EJ, Hsiao K-C, Maggio A, Nakamura K, Kuntzman R, Conney AH. Effect of cigarette smoking on phenacetin metabolism. Clin Pharmacol Ther 1974;15:9-17.
12. Kuntzman R, Pantuck EJ, Kaplan SA, Conney AH. Phenacetin metabolism: effect of hydrocarbons and cigarette smoking. Clin Pharmacol Ther 1976;22:757-64.
13. Kahn GC, Boobis AR, Brodie MJ, Toverud E-L, Murray S, Davies DS. Phenacetin O-deethylase: an activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine? Br J Clin Pharmacol 1985;20:67-76.
14. Lee BL, Benowitz NL, Jacob P. Cigarette abstinence, nicotine gum and theophylline disposition. Ann Int Med 1987;106:553-5.
15. Perel JM, Hurwic MJ, Kanzler MB. Pharmacodynamics of imipramine in depressed patients. Psychopharmacol Bull 1975;11: 16-8.
16. Matsunga SK, Plezia PM, Karol MD, Katz MD, Camilli AE, Benowitz NL. Effects of passive smoking on theophylline clearance. Clin Pharmacol Ther 1989;46:399-407.
17. Butler MA, Lang NP, Young JF, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics. 1992;2:116-27.
18. Bartoli A, Xiaodong S, Cipolla G, Marchiselli R, Gatti G, Perucca E. The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate. Ther Drug Monit 1996,18:586-91.
19. Conney AH, Pantuck EJ, Hsiao K-C, et al. Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clin Pharmacol Ther 1976;20:633-42.
20. Butler MA, Iwasaki M, Guengerich FP, et al. Human cytochrome P-450PA (P4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc Natl Acad Sci USA 1989; 86:7696-7700.
21. Xiaodong S, Gatti G, Bartoli A, Cipolla G, Crema F, Perucca E. Omeprazole does not enhance the metabolism of phenacetin, a marker of cytochrome CYP1A2 activity, in healthy volunteers. Ther Drug Monit 1994;16:248-50.
22. Perucca E, Hedges AM, Makki KA, Richens A. A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme inducing drugs. Br J Clin Pharmacol 1980;10:491-7.
23. Brosen K. Drug interactions and the cytochrome P450 system: the role of the Cytochrome P450 1A2. Clin Pharmacokinet 1995;29 (suppl 1):20-5.